Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects.
Diercks GF, Stroes ES, van Boven AJ, van Roon AM, Hillege HL, de Jong PE, Smit AJ, Gans RO, Crijns HJ, Rabelink TJ, van Gilst WH. Diercks GF, et al. Among authors: van gilst wh, van roon am, van boven aj. Atherosclerosis. 2002 Jul;163(1):121-6. doi: 10.1016/s0021-9150(01)00748-1. Atherosclerosis. 2002. PMID: 12048129
Relation of electrocardiographic abnormalities to levels of serum C-reactive protein.
Asselbergs FW, van Boven AJ, Stuveling EM, Diercks GF, Hillege HL, Kors JA, de Jong PE, van Gilst WH; PREVEND Study Group. Asselbergs FW, et al. Among authors: van gilst wh, van boven aj. Am J Cardiol. 2003 Jun 1;91(11):1358-60. doi: 10.1016/s0002-9149(03)00331-x. Am J Cardiol. 2003. PMID: 12767435 No abstract available.
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, de Zeeuw D, de Jong PE, van Veldhuisen DJ, van Gilst WH; Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators. Asselbergs FW, et al. Among authors: van gilst wh, van boven aj, van veldhuisen dj. Circulation. 2004 Nov 2;110(18):2809-16. doi: 10.1161/01.CIR.0000146378.65439.7A. Epub 2004 Oct 18. Circulation. 2004. PMID: 15492322 Clinical Trial.
Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT]).
Diercks GF, Janssen WM, van Boven AJ, Bak AA, de Jong PE, Crijns HJ, van Gilst WH. Diercks GF, et al. Among authors: van gilst wh, van boven aj. Am J Cardiol. 2000 Sep 15;86(6):635-8. doi: 10.1016/s0002-9149(00)01042-0. Am J Cardiol. 2000. PMID: 10980214 Clinical Trial.
Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study.
Diercks GF, van Boven AJ, Hillege HL, Janssen WM, Kors JA, de Jong PE, Grobbee DE, Crijns HJ, van Gilst WH. Diercks GF, et al. Among authors: van gilst wh, van boven aj. Eur Heart J. 2000 Dec;21(23):1922-7. doi: 10.1053/euhj.2000.2248. Eur Heart J. 2000. PMID: 11071797
Determination of vessel size: a putative framework to assess clinical outcome.
Asselbergs FW, Piers LH, Jessurun GA, van Boven AJ, Veeger NJ, Zijlstra F, van Gilst WH, Tio RA. Asselbergs FW, et al. Among authors: van gilst wh, van boven aj. Int J Cardiol. 2005 Aug 18;103(2):135-9. doi: 10.1016/j.ijcard.2004.08.037. Epub 2004 Dec 19. Int J Cardiol. 2005. PMID: 16080970
125 results